cancer

Trialjectory on track to match 50K cancer patients with clinical trials this year: 35% are from underrepresented groups

Each year millions of people are diagnosed with cancer. Meanwhile, hundreds of clinical trials testing potential treatments are ongoing. But there’s a gap between the people who need treatment and t

Flagship Pioneering’s new venture is betting on tRNA to treat ‘thousands of diseases’

On Tuesday, Flagship Pioneering, the major investor behind Moderna, announced yet another addition to their portfolio of RNA-curious companies. Following a year of hype around mRNA, a new company, cal

YouTube will now ban content with vaccine misinformation

YouTube expanded its medical misinformation policies today to include new guidelines that ban vaccine misinformation. The Google-owned video platform had previously banned over 1 million videos spread

The next healthcare revolution will have AI at its center

Human life expectancy increased from 31 years in 1900 to 72 years in 2017. Today, we are on the cusp of another healthcare revolution driven by artificial intelligence.

Luminate aims to make hair loss from chemotherapy a thing of the past

Hair loss resulting from chemotherapy is one of the most recognizable side effects in all of medicine, and for many is an unwanted public announcement of their condition and treatment. Luminate Medica

Biden proposes ARPA-H, a health research agency to ‘end cancer’ modeled after DARPA

In a joint address to Congress last night, President Biden updated the nation on vaccination efforts and outlined his administration’s ambitious goals. Biden’s first 100 days have been characteriz

C2i, a genomics SaaS product to detect traces of cancer, raises $100M Series B

If you or a loved one has ever undergone a tumor removal as part of cancer treatment, you’re likely familiar with the period of uncertainty and fear that follows. Will the cancer return, and if so,

Resilience is an ambitious bet to improve cancer treatment

Meet Resilience, a new startup that wants to help cancer treatment institutes as well as cancer patients at every step of the treatment journey. It’s an ambitious project founded by two well-known F

Forward Health raises $225M from investors including The Weeknd as it looks to expand nationwide

Primary care startup Forward Health is looking to expand its tech-powered, personalized healthcare model across the U.S., and will use a new $225 million Series D raise to help make it happen. The new

Ibex Medical Analytics raises $38M for its AI-powered cancer diagnostic platform

Israel-based Ibex Medical Analytics, which has an AI-driven imaging technology to detect cancer cells in biopsies more efficiently, has raised a $38 million Series B financing round led by Octopus Ven

New clinical trial data from Locus Biosciences shows promise in CRISPR-Cas3 technology

Antibiotic resistance is one of the biggest potential threats to global health today. But Locus Biosciences is hoping that their crPhage technology might provide a new solution. Based in North Carolin

Senti Bio raises $105 million for its new programmable biology platform and cancer therapies

Senti Biosciences, a company developing cancer therapies using a new programmable biology platform, said it has raised $105 million in a new round of financing led by the venture arm of life sciences

Men’s health subscription startup Numan closes £10M Series A funding round

Launched almost 18 months ago, Numan joined the growing list of sites targeting men’s health, such as Roman and Hims, for example. Numan launched aiming to promote accessible medical remedies for er

Peer Medical allows lung cancer patients to anonymously share treatments with each other

Peer Medical has a big mission. After his father died of lung cancer, serial entrepreneur Ed Spiegel vowed to create a better way for lung cancer patients to deal with their disease. The startup has s

Mission Bio raises $70 million to help scale its tech for improving the development of targeted cancer therapies

California-based startup Mission Bio has raised a new $70 million Series C funding round, led by Novo Growth and including participation from Soleus Capital and existing investors Mayfield, Cota and A

Sight Diagnostics raises $71M Series D for its blood analyzer

Sight Diagnostics, the Israel-based health-tech company behind the FDA-cleared OLO blood analyzer, today announced that it has raised a $71 million Series D round with participation from Koch Disrupti

New telemedicine service The Cusp rolls out at-home hormone test for women to predict menopause

The Cusp, a newly launched startup offering telemedicine services for women in perimenopause and menopause, is launching an at-home hormone test service that slashes the cost of in-office visits and l

Paige, the computational pathology startup targeting cancer, closes a Series B at $70M

Paige, the startup that spun out of the Memorial Sloan Kettering Cancer Center and launched in 2018 to help advance cancer research and care by applying AI to better understand cancer pathology, is to

Bit Bio’s ‘enter button for the keyboard to the software of life’ nabs the company $41.5 million

Bit Bio, the new startup that pitches itself as the “enter button for the keyboard to the software of life,” only needed three weeks to raise its latest $41.5 million round of funding. Ori

Immunai wants to map the entire immune system and raised $20 million in seed funding to do it

For the past two years the founding team of Immunai had been working stealthily to develop a new technology to map the immune system of any patient. Founded by Noam Solomon, a Harvard and MIT-educated
Load More